Physician profile
Sherri E Lee
NPI 1508843434
$2,783.82
in general payments reported to CMS, 2019-2025
14 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $582 · 2022: $885 · 2023: $808 · 2024: $232 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,316.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,253.58 | 2021-2025 | Cardiomems, Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $610.60 | 2021-2025 | Watchman Flx, Watchman Access System, Ekosonic |
| Novartis Pharmaceuticals Corporation | $245.63 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $160.20 | 2023-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $129.72 | 2021-2024 | Verquvo |
| Amgen INC. | $93.76 | 2021-2025 | Repatha |
| Esperion Therapeutics, INC. | $72.72 | 2021-2022 | |
| Pfizer INC. | $69.31 | 2021-2025 | |
| Astellas Pharma US INC | $44.93 | 2022-2023 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.91 | 2021-2022 | |
| Heartflow, INC. | $23.09 | 2025 | |
| Medtronic, INC. | $20.83 | 2025 | Symplicity G3 |
| Bayer Healthcare Pharmaceuticals INC. | $15.93 | 2025 | |
| Janssen Pharmaceuticals, INC | $13.61 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherri Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.